Riew K Daniel, Park Jong-Beom, Cho Yong-Sun, Gilula Louis, Patel Alpesh, Lenke Lawrence G, Bridwell Keith H
Department of Orthopaedic Surgery, Washington University School of Medicine, One Barnes-Jewish Hospital Plaza, Suite 11300 West Pavilion, St. Louis, MO 63110, USA.
J Bone Joint Surg Am. 2006 Aug;88(8):1722-5. doi: 10.2106/JBJS.E.00278.
In a previous prospective, randomized, controlled, double-blinded study on the effect of nerve root blocks on the need for operative treatment of lumbar radicular pain, we found that injections of corticosteroids were more effective than bupivacaine for up to thirteen to twenty-eight months. We performed a minimum five-year followup of those patients who had avoided surgery.
All of the patients were considered to be operative candidates by the treating surgeon, and all had initially requested operative intervention. They had then been randomized to be treated with a selective nerve-root block with either bupivacaine or bupivacaine and betamethasone. Both the treating physician and the patient were blinded to the type of medication. Of fifty-five randomized patients, twenty-nine avoided an operation in the original study. Twenty-one of those twenty-nine patients were reevaluated with a follow-up questionnaire at a minimum of five years after the initial block.
Seventeen of the twenty-one patients still had not had operative intervention. There was no difference between the group treated with bupivacaine alone and the group treated with bupivacaine and betamethasone with regard to the avoidance of surgery for five years. At the five-year follow-up evaluation, all of the patients who had avoided operative treatment had significant decreases in neurological symptoms and back pain compared with the baseline values.
The majority of patients with lumbar radicular pain who avoid an operation for at least one year after receiving a nerve root injection with bupivacaine alone or in combination with betamethasone will continue to avoid operative intervention for a minimum of five years.
在之前一项关于神经根阻滞对腰椎神经根性疼痛手术治疗需求影响的前瞻性、随机、对照、双盲研究中,我们发现,长达13至28个月的时间里,注射皮质类固醇比布比卡因更有效。我们对那些避免了手术的患者进行了至少为期五年的随访。
所有患者均被主刀医生视为手术候选人,且最初均要求进行手术干预。然后他们被随机分为接受布比卡因或布比卡因与倍他米松的选择性神经根阻滞治疗。治疗医生和患者均对所用药物类型不知情。在最初的研究中,55名随机分组的患者中有29名避免了手术。这29名患者中的21名在首次阻滞至少五年后通过随访问卷进行了重新评估。
21名患者中有17名仍未接受手术干预。在避免手术达五年方面,单纯接受布比卡因治疗的组与接受布比卡因和倍他米松治疗的组之间没有差异。在五年随访评估中,所有避免了手术治疗的患者与基线值相比,神经症状和背痛均有显著减轻。
大多数腰椎神经根性疼痛患者在接受单纯布比卡因或布比卡因与倍他米松联合的神经根注射后至少一年避免了手术,且将继续至少五年避免手术干预。